Lee, Danner & Bass’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Lee, Danner & Bass's LLY Position: Q3 2026 in Review
Lee, Danner & Bass increased its Eli Lilly (LLY) stake by 0.67% in Q3 2026, buying an estimated $4.72K and bringing the position to 604 shares worth $699K. The position accounts for 0.04% of the portfolio, ranked #167.
Lee, Danner & Bass first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. The position peaked at $720K in Q2 2026. 4,616 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Lee, Danner & Bass held 604 shares of Eli Lilly worth $699K as of Q3 2026.
- Lee, Danner & Bass bought 4 Eli Lilly shares in Q3 2026, an estimated $4.72K.
- Eli Lilly made up 0.04% of Lee, Danner & Bass's portfolio in Q3 2026, its #167 holding.
- Lee, Danner & Bass first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
- Lee, Danner & Bass's Eli Lilly position peaked at $720K in Q2 2026.
- 4,616 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Lee, Danner & Bass's 13F filing for Q3 2026, filed 27 Oct 2026.